Bio

Prior to Inverness, Dave spent 3 years as a Director of Merchant Banking at Burrill LLC where he focused on strategic advisory for life sciences companies. Prior to Burrill, he was Director of Business Development at CFD Therapeutics Inc., an antibody company "spin-out" from diaDexus, Inc., a molecular Dx company where Dave had previously worked. Prior to CFS, he was an Associate on the Specialty Pharma Equity Research team at Deutsche Bank. Dave began his career in banking with Prudential Vector Healthcare Group. Dave holds a B.A. from Cornell University.